Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

52.51
Delayed Data
As of 4:02pm ET
 -0.35 / -0.66%
Today’s Change
32.83
Today|||52-Week Range
53.49
+46.43%
Year-to-Date

Stock Price Forecast

The 32 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 52.18, with a high estimate of 62.90 and a low estimate of 31.68. The median estimate represents a -0.62% decrease from the last price of 52.51.

Analyst Recommendations

The current consensus among 34 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since December, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.56
Sales
$4.5B
Reporting Date
Feb 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.20%
 
 
 
 
 
 
Growthannually 15.59%
 
 
 
 
 
 

Sales

Growthquarterly 9.06%
 
 
 
 
 
 
Growthannually 11.92%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.